Total submissions: 21
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001802881 | SCV002047633 | benign | Malignant hyperthermia of anesthesia | 2021-12-22 | reviewed by expert panel | curation | This pathogenicity assessment is relevant only for malignant hyperthermia susceptibility (MHS) inherited in an autosomal dominant pattern. Variants in RYR1 can also cause other myopathies inherited in an autosomal dominant pattern or in an autosomal recessive pattern. Some of these disorders may predispose individuals to malignant hyperthermia. RYR1 variants may also contribute to a malignant hyperthermia reaction in combination with other genetic and non-genetic factors and the clinician needs to consider such factors in making management decisions. This sequence variant predicts a substitution of threonine with serine at codon 2787 of the RYR1 protein, p.(Thr2787Ser). The maximum allele frequency for this variant among the six major gnomAD populations is AFR: 0.029867, which is considered to be too common for a pathogenic variant causing autosomal dominantly inherited MHS, BA1. This variant has been classified as Benign. Criteria implemented: BA1. |
Genetic Services Laboratory, |
RCV000147446 | SCV000194873 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000202878 | SCV000257715 | benign | Malignant hypothermia | 2015-06-26 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000209984 | SCV000265729 | benign | Malignant hyperthermia, susceptibility to, 1 | 2013-07-01 | criteria provided, single submitter | research | |
Eurofins Ntd Llc |
RCV000147446 | SCV000333096 | benign | not specified | 2015-07-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000392959 | SCV000412563 | likely benign | Central core myopathy | 2018-02-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000209984 | SCV000412564 | likely benign | Malignant hyperthermia, susceptibility to, 1 | 2018-02-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000335435 | SCV000412565 | likely benign | Congenital multicore myopathy with external ophthalmoplegia | 2018-02-09 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000403812 | SCV000412566 | likely benign | Neuromuscular disease, congenital, with uniform type 1 fiber | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079361 | SCV000660062 | benign | RYR1-related disorder | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000147446 | SCV000730604 | benign | not specified | 2017-04-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000119746 | SCV001145296 | benign | not provided | 2018-12-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000119746 | SCV002498466 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | RYR1: BS1, BS2 |
Fulgent Genetics, |
RCV002498553 | SCV002800437 | benign | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2022-05-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000119746 | SCV003799804 | benign | not provided | 2023-10-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000209984 | SCV004358153 | benign | Malignant hyperthermia, susceptibility to, 1 | 2019-03-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000119746 | SCV005310832 | benign | not provided | criteria provided, single submitter | not provided | ||
Leiden Muscular Dystrophy |
RCV000119746 | SCV000154653 | not provided | not provided | no assertion provided | not provided | ||
Prevention |
RCV001079361 | SCV000305045 | benign | RYR1-related disorder | 2019-05-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000119746 | SCV001800004 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000147446 | SCV001952377 | benign | not specified | no assertion criteria provided | clinical testing |